Financial Symmetry’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Buy
342
+50
+17% +$51.1K 0.14% 42
2026
Q1
$273K Sell
292
-28
-9% -$28.4K 0.1% 49
2025
Q4
$344K Buy
+320
New +$306K 0.14% 41

Other funds holding LLY

Financial Symmetry's LLY Position: Q2 2026 in Review

Financial Symmetry increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $51.1K and bringing the position to 342 shares worth $410K. The position accounts for 0.14% of the portfolio, ranked #42.

Financial Symmetry first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Financial Symmetry held 342 shares of Eli Lilly worth $410K as of Q2 2026.
  • Financial Symmetry bought 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
  • Eli Lilly made up 0.14% of Financial Symmetry's portfolio in Q2 2026, its #42 holding.
  • Financial Symmetry first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Financial Symmetry's 13F filing for Q2 2026, filed 14 Jul 2026.